Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
480 patients around the world
Available in Brazil
EMS
1Research sites
480Patients around the world
This study is for people with
Diabetes
Diabetes mellitus type 2
Requirements for the patient
To 85 Years
All Gender
Medical requirements
Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the consent form.
Diagnosis of type II diabetes mellitus, and who did not reach the therapeutic goal of HbA1c with previous dietary, physical exercise, and previous therapies at stable doses within 3 months.
Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of participants.
History of alcohol abuse or illicit drug use.
Participation in a clinical trial in the year prior to this study.
Pregnancy or risk of pregnancy and lactating participants.
Known hypersensitivity to any of the formula compounds.
Type 1 diabetes.
Sites
EMS - Pharma Farmacêutica
Recruiting
Rod. Jorn. Francisco Aguirre Proença - Parque Odimar, Hortolândia - SP, Brazil
